Consumption of intranasal corticosteroid-containing sprays (INS) for the treatment of allergic rhinitis – a comparison of "real life" prescription data of treatment with budesonide and mometasone in Germany

O. Schöffski & B. Becker
Background and aim: Intranasal corticosteroids (INS) are approved for the treatment of seasonal allergic and persistent rhinitis. Comparison of INS treatment cost often based on the assumption of one single defined daily dose for all different corticosteroids. The aim of the analysis was to quantify[for full text, please go to the a.m. URL]